SURMOUNT-2: Tirzepatide Rings Up Major Weight Loss in T2D ...Middle East

Medscape - News
Weekly tirzepatide injections in adults with type 2 diabetes and overweight or obesity safely produced a 12.8%-14.7% weight loss after 72 weeks in the SURMOUNT-2 pivotal trial. Medscape Medical News

Hence then, the article about surmount 2 tirzepatide rings up major weight loss in t2d was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( SURMOUNT-2: Tirzepatide Rings Up Major Weight Loss in T2D )

Apple Storegoogle play

Last updated :

Also on site :



Latest News